As part of Vertex’s ongoing commitment to patients, the company has established patient support programs to help ensure that qualified patients can access JOURNAVX. For more information visit ...

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy ...

Between Jan. 14 and 26, wire cables were stolen from eight locations in Waterloo. The Waterloo Regional Police Service says the thefts have occurred at car dealerships, commercial businesses and ...

-- JOURNAVX is the first and only approved non-opioid oral pain signal inhibitor and the first new class of pain medicine approved in more than 20 years -- -- JOURNAVX is an effective and well ...

Welcome to the Future This user manual showcases the innovative features and functionalities of your new Magneto Wiring Diagram. Before using your Magneto Wiring Diagram, please familiarize yourself ...

The lifelong activist spent 2,422 days in jail. But through personal loss, injustice and 23 months of solitary confinement, the activist has fought for what he has believed to be right.

The approval was announced in an FDA press release, and it will be sold under the brand name Journavx by Vertex Pharmaceuticals. This painkiller's approval reflects the FDA’s commitment to expanding ...

The approval was announced in an FDA press release, and it will be sold under the brand name Journavx by Vertex Pharmaceuticals. This painkiller's approval reflects the FDA’s commitment to ...